[Corrigendum] Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancer
Wanyuan Chen, Weimin Fan, Guoqing Ru, Fang Huang, Xiaming Lu, Xin Zhang, Xiaozhou Mou, Shibing Wang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Research and Treatments · Virus-based gene therapy research · Immunotherapy and Immune Responses
Oncol Rep 41: 67–76, 2019; DOI: 10.3892/or.2018.6817
Following the publication of the above article, the authors drew to the Editor's attention that certain of the data in Fig. 6 on p. 74 had been assembled incorrectly. Specifically, the data panels showing the results of the SW1990/oVV/H&E and the SW1990/GEM/oVV/H&E experiments, and the SW1990/Gemcitabine/IHC-Smac and the SW1990/GEM/oVV/IHC-Smac experiments, respectively, contained overlapping sections, such that the data, which were intended to show the results of differently performed experiments, had been derived from the same original sources. Furthermore, upon performing an independent analysis of the data in the Editorial Office, it was noted that the data panels selected for the SW1990/oVV-Smac/TUNEL and the SW1990/Gemcitabine&oVV-Smac/TUNEL experiments also contained overlapping sections, and concerning the western blot data shown in Fig. 3B on p. 71, the Survivin protein bands were strikingly similar to data which had appeared in an earlier paper featuring some of the same authors in the journal Scientific Reports.
After having re-examined these figures, the authors realized that these additional cases of data duplication/re-use were also in need of correction. The revised versions of Figs. 3 and 6, now showing the correct data for the SW1990/GEM/oVV/H&E, SW1990/GEM/oVV/IHC-Smac and SW1990/oVV-Smac/TUNEL experiments in Fig. 3, and the correct Survivin western blot data in Fig. 6, are shown on the next page. The authors wish to emphasize that the errors made in terms of the assembly of the data in these figures did not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for granting them this opportunity to publish a Corrigendum, and apologize to both the Editor and the readership for any inconvenience caused.